Childhood immunisation today

Area of Science:

• Immunology
• Biotechnology
• Public Health

Background:

• Advances in understanding infection pathogenesis and host responses, coupled with biotechnology progress, are driving new vaccine development.
• Despite promising vaccine candidates, a significant time lag exists between laboratory development and practical application.
• New vaccines like acellular pertussis and rotavirus are being introduced, with others like varicella, inactivated polio, and hepatitis B vaccines proposed for optimized use.

Purpose of the Study:

• To highlight the progress and challenges in new vaccine development and implementation.
• To emphasize the importance of public information and economic evaluations in vaccine policy.
• To advocate for a rational policy framework for the adoption of novel vaccines.

Main Methods:

• Review of current trends in vaccine development and introduction.
• Analysis of factors influencing vaccine uptake and coverage.
• Discussion of economic evaluation methods for new vaccines.

Main Results:

• Several new vaccines are nearing or undergoing introduction.
• Significant delays are common between vaccine discovery and public availability.
• Economic analyses (cost-benefit, cost-effectiveness, cost-utility) are crucial for informed decision-making.

Conclusions:

• While progress in vaccine science is rapid, practical implementation requires careful consideration of timelines and public engagement.
• Effective communication regarding vaccine properties and usage is essential for maintaining high vaccination coverage.
• Economic analyses provide a necessary foundation for establishing rational and evidence-based vaccination policies.